David Johnson, founder and CEO of GigaMune, sits down with Neil to discuss his company's efforts to develop in vivo cell and gene therapies to treat cancer and autoimmune conditions.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
